SELECT ISSUE

Revista Romana de PEDIATRIE | Volumul LX, Nr. 3, An 2011
ISSN 1454-0398  |  e-ISSN 2069-6175
ISSN-L 1454-0398

Indexed in / abstracted by

Thomson Reuters Embase
Scopus Cross-ref
Index Copernicus
Ulrichs Ebsco Host
Medline - Ebsco PubMed

HIGHLIGHTS

Publicarea de articole stiintifice

Stimati cititori, va reamintim ca autorii primi ai articolelor stiintifice pot acumula 80 de credite EMC in urma publicarii. Daca un articol are mai multi autori, cele 80 de credite [...]

Premiul Societatii pentru autori

Incepand cu 2016, Societatea Romana de Pediatrie ofera Premiul Societatii - pentru autorii celor mai bune articole stiintifice publicate [...]

Plagiatul – in actualitate

Tema plagiatului este tot mai mult discutata in ultima vreme. Aparitia unor programe performante de cautare si identificare a similitudinilor intre texte [...]

Neonatal hyperthyroidism – discussions on three clinical cases

, , , and

ABSTRACT

Introduction: Neonatal hyperthyroidism occurs în infants from mothers with Graves Basedow, with an incidence of 1:70.

Purpose: Highlighting the risks and complications that may appear în infants of mothers with Graves’ disease.

Method: The cases of three newborns resulted from risk pregnancies (mothers known with Graves’ disease) diagnosed with neonatal hyperthyroidism, are addressed. Admission status and evolution of each case were different, depending on the mother’s compliance regarding the treatment and on the mothers (TSI) antibody levels. în the first case, admitted at the age of one day with thyrotoxicosis, the mother interrupted treatment throughout pregnancy. In the two cases which followed treatment during pregnancy, mothers TSI level during pregnancy was different: the patient with high TSI levels originally developed subclinical hypothyroidism due to transplacental passage of oral antithyroid medication, subsequently developing clinical symptoms of hyperthyroidism (agitation, tachycardia, growth retardation). In the third case, the mother’s hard to control, persistent, thyrotoxicosis, throughout the whole pregnancy, affected the intrauterine development (gestational week 33 weeks). He presented with a mild form of hyperthyroidism caused by low amounts TSI antibodies during the pregnancy. The evolution was favorable with the normalization of the thyroid function; at the age of 3 months, no maternal antibodies have been detected in infants.

Discussion: The risk of newborn thyrotoxicosis represents an emergency, antithyroid treatment followed by the mother has an essential role; high doses increase the risk of perinatal hypothyroidism. The severity of the symptoms depends on the antibody (TSI) levels which cross the placenta.

Conclusions: Monitoring the newborn from mothers with Graves’ disease is essential; it should begin from the intrauterine period and continued until at the age of 3-6 months. Reaching euthyroidism în both mother and the newborn is difficult to obtain and requires interdisciplinary collaboration

Key words: newborn, transient neonatal hypo-/hyperthyroidism, Grave’s disease

Full text | PDF

Leave a Reply